transthyretin ttr tbpa transport protein plasma cerebrospinal fluid transports thyroid hormone thyroxine retinol liver transthyretin gained name transports thyroxine retinol liver secretes ttr blood choroid plexus secretes ttr cerebrospinal fluid ttr originally called thyroxinebinding prealbumin migrated faster albumin electrophoresis gels prealbumin felt misleading name synthetic precursor albumin alternative name ttr proposed dewitt goodman transthyretin protein encoded ttr gene located chromosome functions concert two thyroid hormonebinding proteins serum cerebrospinal fluid ttr primary carrier ttr also acts carrier retinol vitamin association retinolbinding protein rbp blood csf less ttrs binding sites occupied blood taken advantage prevent ttrs dissociation misfolding aggregation leads degeneration postmitotic tissue numerous small molecules known bind thyroxine binding sites including many natural products resveratrol drugs flufenamic toxicants ttr homotetramer dimer dimers quaternary structure synthesized liver choroid plexus retinal pigment epithelium secretion bloodstream cerebrospinal fluid eye respectively monomer polypeptide rich beta sheet structure association two monomers via edge betastrands forms extended beta sandwich association two dimers facetoface fashion produces homotetrameric structure creates two thyroxine binding sites per tetramer dimerdimer interface comprising two binding sites weaker dimerdimer interface one comes apart first process tetramer ttr misfolding aggregation known associated amyloid including wildtype transthyretin hereditary transthyretin familial amyloid polyneuropathy familial amyloid cardiomyopathy ttr tetramer dissociation known ratelimiting amyloid fibril however monomer also must partially denature order ttr misassembly competent leading variety aggregate structures including amyloid least diseasecausing mutations gene wild type ttr dissociate misfold aggregate leading ssa senile systemic amyloidosis point mutations within ttr known destabilize tetramer composed mutant wildtype ttr subunits facilitating facile dissociation andor misfolding replacement valine methionine position ttr mutation commonly associated position replacement valine isoleucine ttr carried africanamerican population common cause ssa estimated affect population age severity disease varies greatly mutation mutations causing disease first second decade life others benign deposition ttr amyloid generally observed extracellularly although ttr deposits also clearly observed within cardiomyocytes heart treatment familial hereditary ttr amyloid disease historically relied liver transplantation crude form gene ttr primarily produced liver replacement liver containing mutant ttr gene normal gene able reduce mutant ttr levels body pretransplant levels certain mutations however cause cns amyloidosis due production choroid plexus cns ttr amyloid diseases respond gene therapy mediated liver transplantation european medicines agency approved tafamidis vyndaqel amelioration tafamidis kinetically stabilizes ttr tetramer preventing tetramer dissociation required ttr amyloidogenesis degradation autonomic nervous andor peripheral nervous system andor ttr also thought beneficial side effects binding infamous betaamyloid protein thereby preventing betaamyloids natural tendency accumulate plaques associated early stages alzheimers disease preventing plaque formation thought enable cell rid otherwise toxic protein form thus help prevent maybe even treat strong pharmacologic data see european medicines agency website tafamidis clinical trial results indicating process amyloid fibril formation leads degeneration postmitotic tissue causing fap likely fac ssa evidence points oligomers generated process amyloidogenicity leading observed transthyretin level cerebrospinal fluid also found lower patients neurobiological disorders reduced level transthyretin csf may indicate lower thyroxine transport brains patients schizophrenia transthyretin known contain gla domain thus dependent production posttranslational modification requiring vitamin k potential link vitamin k status thyroid function explored transthyretin made part choroid plexus used immunohistochemical marker choroid plexus papillomas well carcinomascitation needed march two ongoing clinical trials undergoing recruitment united states worldwide evaluate potential treatments ttr update transthyretin shown interact human transthyretin prealbumin complex flufenamic acid amino benzoic acid human transthyretin prealbumin transthyretin del tertiary structures three amyloidogenic transthyretin variants implications amyloid fibril formation tertiary structures three amyloidogenic transthyretin variants implications amyloid fibril formation crystal structure human transthyretin crystal structure human transthyretin complex resveratrol crystal structure human transthyretin complex flurbiprofen crystal structure human transthyretin complex acid crystal structure human transthyretin complex diclofenac crystal structure transthyretin complex nmtrifluoromethylphenyl acid crystal structure human transthyretin complex otrifluoromethylphenyl anthranilic acid structure human transthyretin complexed bromophenols new mode binding structure human transthyretin complexed bromophenols new mode binding structure human transthyretin complexed bromophenols new mode binding xray crystal structure refinements normal human transthyretin amyloidogenic val variant angstroms resolution xray crystal structure refinements normal human transthyretin amyloidogenic val variant angstroms resolution crystal structure human transthyretin resolution transthyretin protein stabilisation transthyretin stability key factor amyloidogenesis transthyretin stability key factor amyloidogenesis crystal structure highly amyloidogenic transthyretin mutant ttr engineered transthyretin monomer nonamyloidogenic unless partially denatured monoclinic form human transthyretin complexed thyroxine crystal structure transthyretin mutant ttr collected room temperature crystal structure transthyretin mutant ttr collected cryo temperature crystal structure transthyretin mutant ttr structure human retinol binding protein carrier protein transthyretin reveals interaction carboxy terminus rbp covalent dimer transthyretin affects amyloid pathway retinol binding protein complexed transthyretin crystal structure transthyretin mutant solved space group crystal structure transthyretin mutant solved space group mechanism molecular recognition structural aspects binding human serum transthyretin crystal structure determination human complex structural aspects inotropic bipyridine binding crystal structure determination angstroms human serum transthyretinmilrinone complex tertiary structures three amyloidogenic transthyretin variants implications amyloid fibril formation orthorhombic crystal structure transthyretin complex diethylstilbestrol xray crystal structure refinements normal human transthyretin amyloidogenic variant angstroms resolution xray crystal structure refinements normal human transthyretin amyloidogenic variant angstroms resolution xray crystal structure refinements normal human transthyretin amyloidogenic variant angstroms resolution cardiomyopathic mutant transthyretin complex retinoic acid monoclinic crystal structure transthyretin complex diethylstilbestrol transthyretin tethered inhibitor one monomer xray crystallographic structure amyloidogenic variant ttr structure ttr nonamyloidogenic variant protective clinical effects crystal structure transthyretin complex iododiflunisal human transthyretin also called prealbumin complex acid crystal structure human transthyretin bound iodide crystal structure human transthyretin bound chloride crystal structure complex amyloidogenic variant transthyretin leu pro crystal structure complex human transthyretin crystal structure complex amyloidogenic variant transthyretin human transthyretin ttr complexed diflunisal analogues acid human transthyretin ttr complexed diflunisal analogues acid human transthyretin ttr complexed diflunisal analogues ttr acid human transthyretin ttr complexed benzoxazole human transthyretin ttr complexed bivalant amyloid inhibitor carbon linker human transthyretin ttr complexed bivalant amyloid inhibitor carbon linker crystal structure transthyretin mutant acidic ph crystal structure transthyretin mutant low ph crystal structure transthyretin mutant neutral ph crystal structure human transthyretin ph human transthyretin ttr complexed hydroxylated polychlorinated human transthyretin ttr complexed hydroxylated polychlorinated human transthyretin ttr complexed hydroxylated polychlorinated crystal structure sulfonated transthyretin crystal structure transthyretin mutant ph structure prealbumin secondary tertiary quaternary interactions determined fourier refinement angstroms transthyretin also called prealbumin complex thyroxine transthyretin also called prealbumin complex tertiary structures three amyloidogenic transthyretin variants implications amyloid fibril formation tertiary structures three amyloidogenic transthyretin variants implications amyloid fibril formation leu pro transthyretin crystal structure httpsenwikipediaorgwikitransthyretin